의료진프로필

Real-world Data on the Diagnosis, Treatment and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT study

Sim, YK; Chong, MC; Gandhi, M; Pokharkar, YM; Zhu, YA; Shi, LM; Lequn, L; Chen, CH; Kudo, M; Lee, JH; Strasser, S; Chanwat, R; Chow, PKH

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma

Song, BG; Choi, SC; Goh, MJ; Kang, WS; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW

Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII

Song, BG; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW; Sinn, DH

Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B

Oh, JH; Park, Y; Goh, MJ; Sinn, DH; Ahn, SB; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW

Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study

Chang, JI; Kim, JH; Sinn, DH; Cho, JY; Kim, KM; Oh, JH; Park, Y; Sohn, W; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors

Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS

Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis

Goh, MJ; Kim, J; Chang, WH; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Kang, WS

The First Case of Clostridium saudiense Bacteremia in a Patient with Hepatocellular Carcinoma

Yoon, E; Kim, TY; Heo, WY; Kang, O; Yu, HJ; Lee, JH; Ko, JH; Lee, NY; Huh, HJ

Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development

Chang, JI; Sinn, DH; Jeong, WK; Hwang, JA; Won, HY; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis

Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC

Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea

Song, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy

Goh, MJ; Kang, W; Jeong, WK; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients

Kim, HJ; Kim, JH; Yeon, JE; Seo, YS; Jang, JW; Cho, YK; Jang, BK; Han, BH; Lee, C; Lee, JH; Yoon, JH; Kim, KM; Kim, MY; Kim, DY; Park, NH; Cho, EY; Lee, JS; Lee, JW; Kim, IH; Song, BC; Lee, BS; Kwon, OS

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

Hong, JY; Cho, HJ; Sa, JK; Liu, XQ; Ha, SY; Lee, T; Kim, H; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, HC; Kang, TW; Rhim, H; Lee, SJ; Cristescu, R; Lee, J; Paik, YH; Lim, HY

Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase

Seong, G; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH

Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B

Goh, MJ; Kang, W; Kim, KM; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels

Chang, JI; Sinn, DH; Cho, H; Kim, S; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study

Gandhi, M; Ling, WH; Chen, CH; Lee, JH; Kudo, M; Chanwat, R; Strasser, SI; Xu, Z; Lai, SH; Chow, PKH

Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response

Na, JE; Sinn, DH; Lee, JH; Jang, HJ; Baek, SY; Kim, KA; Kang, WS; Gwak, GY; Paik, YH; Kim, YJ; Choi, MS; Yoon, JH; Lee, JH; Koh, KC; Paik, SW

The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study

Park, Y; Sinn, DH; Oh, JH; Goh, MJ; Kim, K; Kang, W; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Gwak, GY

Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure

Kim, JE; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy

Oh, JH; Lee, HW; Sinn, DH; Park, JY; Kim, BK; Kim, SU; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH

Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease

Oh¹, JH; Lee, JH; Cho, MS; Kim, H; Chun, J; Lee, JH; Yoon, Y; Kang, W

A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients

Song¹, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma

Lee¹, JS; Chon, YE; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Han, KH; Kang, W; Choi, MS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Kim, HY; Kim, TH; Yoo, K; Ha, Y; Kim, MN; Lee, JH; Hwang, SG; Kim, SS; Cho, HJ; Cheong, JY; Cho, SW; Park, SH; Heo, NY; Hong, YM; Yoon, KT; Cho, M; Park, JG; Kang, MK; Park, SY; Kweon, YO; Tak, WY; Jang, SY; Sinn, DH; Kim, SU

Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea

Goh¹, MJ; Oh, JH; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance

Park¹, Y; Lee, JH; Sinn, DH; Park, JY; Kim, MA; Kim, YJ; Yoon, JH; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal

Song¹, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients

Kim¹, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria

Oh¹, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events

Oh¹, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH

Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients

Kim¹, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-Functional cure unlikely

Cho¹, JY; Sohn, W; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, CG

Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma

Song¹, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS

Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea

Kim¹, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance

Kim¹, HK; Kang, W; Sinn, DH; Lee, JH; Kim, WS; Kim, SJ

Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia

Kim¹, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma

Kim¹, JM; Kwon, CHD; Joh, JW; Yoo, H; Kim, K; Sinn, DH; Choi, GS; Lee, JH

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data

Yoon¹, JS; Song, BG; Lee, JH; Lee, HY; Kim, SW; Chang, Y; Lee, YB; Cho, EJ; Yu, SJ; Sinn, DH; Kim, YJ; Lee, JH; Yoon, JH

Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?

Kim¹, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW

Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up

Lee¹, JH; Lee, JH; Lim, YS; Yeon, JE; Song, TJ; Yu, SJ; Gwak, GY; Kim, KM; Kim, YJ; Lee, JW; Yoon, JH

Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients

Sinn¹, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy

Song¹, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy

Bae¹, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW

Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?

Kim¹, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization

Kim¹, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia

Paik¹, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation

Oh¹, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Baracle (R) vs Baraclude (R) for 48 weeks in patients with treatment-naive chronic hepatitis B: a comparison of efficacy and safety

Kim¹, DY; Kim, JH; Tak, WY; Yeon, JE; Lee, JH; Yoon, JH; Lee, YJ; Lee, BS; Han, BH; Lee, HC

Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture

Yoo¹, GS; Park, HC; Il Yu, J; Lim, DH; Cho, WK; Lee, E; Jung, SH; Han, Y; Kim, ES; Lee, SH; Eoh, W; Park, SJ; Chung, SS; Lee, CS; Lee, JH

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial

Yu¹, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW

Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment

Kim¹, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response

Cho¹, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study

Lee¹, JH; Tak, WY; Lee, Y; Heo, MK; Song, JS; Kim, HY; Park, SY; Bae, SH; Lee, JH; Heo, J; Kim, KH; Bae, YS; Kim, YJ

A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels

Sinn¹, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients

Kim JH1¹, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma

Kim JH1¹, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Nonanatomical resection is comparable with anatomical resection in solitary hepatocellular carcinoma < 5 cm in the right posterior section

Kim JM1¹, Kwon CH, Joh JW, Na BG, Lee KW, Choi GS, Lee JH.

Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma

Kim JH1¹, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma

Kim JH1¹, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?

Kim KM1¹, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.

Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index

Lee K1¹, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study

Kim JH1¹, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma

Sohn W1¹,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.

Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial

Yu JI1¹, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.

Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study

Mueller JL1¹,2, King LY1,2, Johnson KB1,2, Gao T3, Nephew LD4, Kothari D2,5, Simpson MA6, Zheng H7, Wei L8, Corey KE1,2, Misdraji J9, Lee JH10, Lin MV1,2, Gogela NA1,2, Fuchs BC2,8, Tanabe KK2,8, Gordon FD2,6, Curry MP2,5, Chung RT1,2.

Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease

Hong YS1¹, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease

Ahn JM1¹, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation

Kim JM1¹, Kwon CH1, Joh JW1, Han SB2, Sinn DH3, Choi GS1, Kang ES4, Lee JH3, Kim GS2, Lee SK1.

Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study

Yu JI1¹, Park JW2, Park HC3, Yoon SM4, Lim do H1, Lee JH5, Lee HC6, Kim SW7, Kim JH2.

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods

Kim JM1¹, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.

Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents

Shin JH1¹, Kwon HJ, Jang HR, Lee JE, Gwak GY, Huh W, Jung SH, Lee JH, Kim YG, Kim DJ, Oh HY.

Feasibility of alpha-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea

Ahn DG1¹, Kim HJ1, Kang H2, Lee HW1, Bae SH3, Lee JH4, Paik YH4, Lee JS5.

Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors

Kim HJ1¹, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels

Ahn JM1¹,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy

Lee JY1¹, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.

Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels

Lee J1¹, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.

Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load

Sinn DH1¹, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.

Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load

Sohn W1¹, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma

Lee JH1¹, Lee JH2, Lim YS3, Yeon JE4, Song TJ5, Yu SJ2, Gwak GY1, Kim KM3, Kim YJ2, Lee JW6, Yoon JH7.

Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors

Sohn W1¹, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma

Korean Liver Cancer Study Group (KLCSG); National Cancer Center¹, Korea (NCC).

Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread

Sinn DH1¹, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women

Sinn DH1¹, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses

Huang CS¹, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.

Intrahepatic Metastasis is More Risky than Multiple Occurrence in Hepatocellular Carcinoma Patients after Curative Liver Resection

Kim JM¹, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK.

Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma

Kim JM1¹, Cho BI1, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim SJ1, Paik SW3, Park CK4.

Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy A Matched Study

Kim JM1¹, Kwon CH, Joh JW, Sinn DH, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.

Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients

Kim HJ1¹,?Cho JY1,?Kim YJ1,?Gwak GY1,?Paik YH1,?Choi MS1,?Koh KC1,?Paik SW1,?Yoo BC1,?Lee JH1.

Outcomes After Curative Hepatectomy in Patients with Non-B Non-C Hepatocellular Carcinoma And Hepatitis B Virus Hepatocellular Carcinoma From Non-Cirrhotic Liver

Kim JM1¹, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.

Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease

Cho JY1¹, Paik YH1, Sohn W1, Cho HC2, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Brivanib as Adjuvant Therapy to Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Randomized Phase III Trial

Kudo M1¹, Han G, Finn RS, Poon RT, Blanc JF, Yan L, Yang J, Lu L, Tak WY, Yu X, Lee JH, Lin SM, Wu C, Tanwandee T, Shao G, Walters IB, Dela Cruz C, Poulart V, Wang JH.

The Effect of Hepatocellular Carcinoma Bile Duct Tumor Thrombi in Liver Transplantation

Kim JM¹, Kwon CH, Joh JW, Park JB, Gwak MS, Lee JH, Kim GS, Kim SJ, Lee SK.

Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors

Sohn W1¹, Choi MS1, Cho JY1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study

Min YW1¹, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.

Hepatitis B Virus Reactivation During Anti-Cancer Chemotherapy in Patients with Past Hepatitis B Virus Infection

Kim E¹, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma

Shin JU1¹, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.

Relationship of Liver Stiffness and Controlled Attenuation Parameter Measured by Transient Elastography with Diabetes Mellitus in Patients with Chronic Liver Disease

Ahn JM1¹, Paik YH1, Kim SH1, Lee JH1, Cho JY1, Sohn W1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma

Sohn W1¹, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease

Sinn DH1¹, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.

The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma

Cho JY1¹, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Long- term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching

Min YW1¹, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients

Kim JM1¹, Park H1, Jang HR2, Park JB1, Kwon CH1, Huh W2, Lee JH2, Kim SJ1, Joh JW1.

Single hepatocellular carcinoma <= 3 cm in left lateral segment: Liver resection or radiofrequency ablation

Kim JM1¹, Kang TW1, Kwon CH1, Joh JW1, Ko JS1, Park JB1, Rhim H1, Lee JH1, Kim SJ1, Paik SW1.

Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma

Kim JM1¹, Kwon CH1, Joh JW2, Park JB1, Lee JH3, Kim GS4, Kim SJ1, Paik SW3, Lee SK1.

Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation

Sohn W1¹, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A

Kim JM1¹, Kwon CH1, Joh JW1, Park JB1, Lee JH2, Kim GS3, Kim SJ1, Paik SW2.

Differences Between Hepatocellular Carcinoma and Hepatitis B Virus Infection in Patients With and Without Cirrhosis

Kim JM1¹, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.

Clinical Features, Image Findings, and Prognosis of Inflammatory Pseudotumor of the Liver: A Multicenter Experience of 45 Cases

Park JY1¹, Choi MS1, Lim YS2, Park JW2, Kim SU3, Min YW1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

A nationwide seroepidemiology of hepatitis C virus infection in South Korea

Kim do Y1¹, Kim IH, Jeong SH, Cho YK, Lee JH, Jin YJ, Lee D, Suh DJ, Han KH, Park NH, Kang HY, Jung YK, Kim YS, Kim KA, Lee YJ, Lee BS, Yim HJ, Lee HJ, Baik SK, Tak WY, Lee SJ, Chung WJ, Choi SK, Cho EY, Heo J, Kim DJ, Song BC, Kim MW, Lee J, Chae HB, Choi DH, Choi HY, Ki M.

Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Min YW1¹,?Kim J,?Kim S,?Sung YK,?Lee JH,?Gwak GY,?Paik YH,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.

Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures

Kim YJ1¹,?Sinn DH,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.

A Case of Nonalcoholic Steatohepatitis and Small Intestinal Bacterial Overgrowth with Peripheral Edema Caused by Intestinal Bypass Surgery and Relieved by Repair

Sung YK1¹,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.

Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B

Kim JH1¹, Kwon SY, Lee YS, Lee JH, Lee YS, Lee CH.

Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients

Kim YJ1¹,?Cho HC,?Sinn DH,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.

Virological response to adefovir monotherapy and the risk of adefovir resistance

Sinn DH1¹,?Lee HIe,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Lee JH.

Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score

Cho HC1¹,?Jung HY,?Sinn DH,?Choi MS,?Koh KC,?Paik SW,?Yoo BC,?Kim SW,?Lee JH.

Long-term Treatment Outcomes for Autoimmune Hepatitis in Korea

Kil JS1¹,?Lee JH,?Han AR,?Kang JY,?Won HJ,?Jung HY,?Lim HM,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC.

Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices

Choi YS1¹,?Lee JH,?Sinn DH,?Song YB,?Gwak GY,?Choi MS,?Koh KC,?Paik SW,?Yoo BC.

Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: A prospective follow-up study

Kim JH1¹,?Lee JH,?Park SJ,?Bae MH,?Kim JH,?Kim do Y,?Kim JK,?Choi MS,?Koh KC,?Paik SW,?Yoo BC.

Clinical significance of enlarged perihepatic lymph nodes in chronic hepatitis B

Choi MS1¹, Lee JH, Koh KC, Paik SW, Rhee PL, Kim JJ, Rhee JC, Choi KW, Kim SH.